Literature DB >> 10990243

Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.

M Gattorno1, S Vignola, G Barbano, M P Sormani, F Sabatini, A Buoncompagni, P Picco, V Pistoia.   

Abstract

OBJECTIVE: Animal models of immune complex mediated tissue injury have shown that tumor necrosis factor (TNF) and TNF induced adhesion molecules play an important role in the pathogenesis of tissue damage mediated by IgG, but not in that mediated by IgA, immune complexes. We compared possible differences in the behavior of 2 TNF induced adhesion molecules (VCAM-1 and ICAM-1) in Henoch-Schönlein purpura (HSP), which is characterized by the formation of IgA immune complexes, versus systemic lupus erythematosus (SLE), which is mostly associated with the vascular deposition of IgG immune complexes.
METHODS: Serum concentrations of soluble (s)VCAM-1 and ICAM-1 were determined by ELISA methods in 20 patients with pediatric SLE showing variably active disease, 20 active patients with active HSP, and 19 healthy controls. TNF-alpha as well as p55 and p75 soluble receptors (sTNF-R) were simultaneously tested by enzyme amplified sensitivity immunoassay in 22 patients (12 SLE, 10 HSP).
RESULTS: Serum sVCAM-1 concentration was significantly higher in patients with SLE (mean +/- SD, 608 +/- 76 ng/ml), than in patients with HSP (501.9 +/- 63.3 ng/ml) and controls (446.8 +/- 139.2 ng/ml) (p < 0.001). In SLE patients, sVCAM-1 correlated positively with ESR (r = 0.45, p = 0.02) and negatively with C4 serum levels (r = -0.57, p = 0.004), platelets (r = -0.38, p = 0.03), and lymphocyte count (r = -0.42, p = 0.03). No differences in sICAM-1 serum concentrations were detected among SLE, HSP, or control groups. Soluble VCAM, but not sICAM-1, showed a positive correlation with TNF-alpha (r = 0.71, p = 0.01), p55 (r = 0.63, p = 0.02), and p75 (r = 0.7, p = 0.01) sTNF-R serum concentrations in SLE, but not in patients with HSP.
CONCLUSION: Our study provides additional evidence of a possible differential involvement of TNF and TNF induced adhesion molecules in the pathogenesis of tissue damage between pediatric SLE and HSP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10990243

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Leptin levels in Henoch-Schönlein purpura.

Authors:  Yuksel Aliyazicioglu; Ozan Ozkaya; Husamettin Yakut; Ismail Islek; Muhlise Alvur
Journal:  Clin Rheumatol       Date:  2006-07-01       Impact factor: 2.980

2.  The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura.

Authors:  Tae-Sun Ha
Journal:  Pediatr Nephrol       Date:  2004-12-31       Impact factor: 3.714

Review 3.  Henoch-Schönlein purpura.

Authors:  Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

4.  CTLA-4 +49 A/G genotype and HLA-DRB1 polymorphisms in Turkish patients with Henoch-Schönlein purpura.

Authors:  Oguz Soylemezoglu; Harun Peru; Sevim Gonen; Aysun Cetinyurek; Ozan Ozkaya; Sevcan Bakkaloğlu; Necla Buyan; Enver Hasanoglu
Journal:  Pediatr Nephrol       Date:  2008-05-01       Impact factor: 3.714

5.  The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Schönlein purpura.

Authors:  Y-H Yang; S J Wang; Y-H Chuang; Y-T Lin; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

6.  Correlation between serum inflammatory factors TNF-α, IL-8, IL-10 and Henoch-Schonlein purpura with renal function impairment.

Authors:  Liangdong Yuan; Quanyi Wang; Shiqi Zhang; Ling Zhang
Journal:  Exp Ther Med       Date:  2018-02-16       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.